Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Annexon Inc
(NQ:
ANNX
)
4.960
+0.260 (+5.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Annexon Inc
< Previous
1
2
3
4
5
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
May 25, 2023
Via
Benzinga
Dow Drops 100 Points; US GDP Tops Estimates
May 25, 2023
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining over 1% on Thursday. Following the market opening Thursday, the Dow traded down 0.34% to 32,687.15 while the NASDAQ rose 1.36%...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 25, 2023
Via
Benzinga
Annexon's Eye Disease Drug Reports Mixed Trial Results, Will Focus On Planned Late-Stage Study
May 25, 2023
Via
Benzinga
Analyst Ratings for Annexon
May 09, 2023
Via
Benzinga
The Latest Analyst Ratings for Annexon
April 19, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 25, 2023
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
Annexon Topline Data from ARCHER Phase 2 Trial of ANX007 in Geographic Atrophy Demonstrated Statistically Significant, Dose-Dependent Preservation of Visual Function
May 24, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progress
May 08, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
March 06, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conference
February 27, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises
January 08, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Appoints Industry Veteran, Dr. Rick Artis, as Chief Scientific Officer to Support the Advancement and Expansion of Complement-focused Portfolio
January 06, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2022
From
Annexon Biosciences
Via
GlobeNewswire
Annexon: Q3 Earnings Insights
November 03, 2022
Annexon (NASDAQ:ANNX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Annexon beat estimated earnings by...
Via
Benzinga
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
November 03, 2022
From
Annexon Biosciences
Via
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2022
From
Annexon Biosciences
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
September 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 12, 2022
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
July 08, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
79 Biggest Movers From Yesterday
June 08, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.